Prot# PDX-012: A Randomized, Phase 2b, Multi-Center Study of Pralatrexate Versus Erlotinib in Patients with Stage IIIB/IV Non-Small Cell Lung Cancer After Failure of at Least 1 Prior Platinum-Based Treatment

  • Patel, Jyoti D (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date10/1/08 → 10/1/11

Funding

  • Allos Therapeutics, Inc. (PDX-012)